Status:
COMPLETED
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the effectiveness and safety of 3 doses of paliperidone palmitate in treating subjects with schizophrenia.
Detailed Description
This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter, dose-response study of patients who have a Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM ...
Eligibility Criteria
Inclusion
- A DSM-IV diagnosis of schizophrenia (disorganized, catatonic, paranoid, residual, or undifferentiated type) for at least 1 year before the screening evaluation
- a total PANSS score of 70 to 120 at screening and baseline (pre-treatment) evaluations
- a body mass index (BMI \[weight (kilograms)\]/\[height (meters)\]²) of more than 17.0 kg/m²
Exclusion
- A primary active DSM-IV Axis I diagnosis other than schizophrenia
- a decrease of 25% or more in the total PANSS score between screening and baseline evaluations
- a DSM-IV diagnosis of active substance dependence within 3 months of screening evaluation
- a history of treatment resistance as defined by failure to respond to 2 adequate trials of different antipsychotic medications
- a woman who is pregnant, breast-feeding, or planning to become pregnant during the study period.
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
366 Patients enrolled
Trial Details
Trial ID
NCT00210548
Start Date
April 1 2005
End Date
June 1 2006
Last Update
June 8 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.